Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases

globenewswire

Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases – NEWSnet – News… as it used to be

More Press Releases

May 15, 2026

Froelick Gallery presents V. Maldonado solo exhibition

May 15, 2026

Florida Entrepreneur Irene Namer Receives Consecutive Greater Hollywood Chamber Recognition

May 15, 2026

Intermountain Health Experts Provide Tips to Staying Safe While Playing Pickleball

May 15, 2026

Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases

Froelick Gallery presents V. Maldonado solo exhibition

Florida Entrepreneur Irene Namer Receives Consecutive Greater Hollywood Chamber Recognition

Intermountain Health Experts Provide Tips to Staying Safe While Playing Pickleball

Ruvna Launches Dismissal, Bringing Real-Time Student Visibility to Independent K-12 Schools